Neurocrine Biosciences Inc. (NBIX) declined -5.38% or -4.91 to $86.32. It is approximately 767386 shares traded, which is 107.07% compare to the average total volume 716734. The market cap of NBIX is $7.84 billion. The year to date change is 24.78%. The 52 week price range is from $64.72 to $126.98. Price of NBIX have changed 3.74% during last week. It have changed 18.70% over last month, 8.07% over last 3 months, -18.74% over last 6 months and 15.22% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NBIX is 84.15. It is -2.51% below current price. The 200-day Moving Averages for NBIX is 97.74. It is 13.23% above current price. The 52-week High is 126.98. It is 47.10% from the current price. The 52-week Low is 64.72. It is -25.02% from current price.
There are some statistics of NBIX. It is has market cap $7.84 billion. The share outstanding is 90.82 million. The average volume is 716734. The percent of top 15 Institution holding is 171.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NBIX is 5.04%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NBIX is 2.38%.